Glucose transporter-1 (GLUT-1): a potential marker of prognosis in rectal carcinoma?
Valentine, Helen R
Görken, I B
West, Catharine M L
AffiliationDepartment of Radiation Oncology, Dokuz Eylül University Medical School, Inciraltu, Izmir 35340, Turkey. firstname.lastname@example.org
MetadataShow full item record
AbstractThe aim of the study is to evaluate the pattern and level of expression of glucose transporter-1 (GLUT-1) in rectal carcinoma in relation to outcome as a potential surrogate marker of tumour hypoxia. Formalin-fixed tumour sections from 43 patients with rectal carcinoma, who had undergone radical resection with curative intent, were immunohistochemically stained for GLUT-1. A mean of three sections per tumour (range 1-12) were examined. Each section was semiquantitatively scored; 0, no staining; 1, <10%; 2, 10-50%; 3, >50% and a score given for the whole section, the superficial (luminal) and deep (mural) part of the tumour. Staining was seen in 70% of tumours. Increased staining was noted adjacent to necrosis and ulceration. A diffuse and patchy pattern of staining, with and without colocalisation to necrosis was seen. Patients with high GLUT-1-expressing tumours (score 3 vs 0-2) had a significantly poorer overall survival (P=0.041), which was associated with poorer metastasis-free survival with no difference in local control. No significant correlation was seen with other prognostic factors. There was a strong correlation between the score for the superficial and deep parts of the tumour (r=0.81), but a significant relationship with outcome was only found in the deep part (P=0.003 vs P=0.46). In conclusion, increased GLUT-1 expression in rectal tumours was an adverse prognostic factor and is worth further evaluation as a predictive marker of response to therapy.
CitationGlucose transporter-1 (GLUT-1): a potential marker of prognosis in rectal carcinoma? 2003, 89 (5):870-6 Br. J. Cancer
JournalBritish Journal of Cancer
- Glut-1 glucose transporter expression in esophageal squamous cell carcinoma is associated with tumor aggressiveness.
- Authors: Kato H, Takita J, Miyazaki T, Nakajima M, Fukai Y, Masuda N, Fukuchi M, Manda R, Ojima H, Tsukada K, Kuwano H
- Issue date: 2002 Sep-Oct
- Glucose transporter-1 expression in renal cell carcinoma and its correlation with hypoxia inducible factor-1 alpha.
- Authors: Lidgren A, Bergh A, Grankvist K, Rasmuson T, Ljungberg B
- Issue date: 2008 Feb
- Coexpression of hypoxia-inducible factor-1α and glucose transporter-1 is associated with poor prognosis in oral squamous cell carcinoma patients.
- Authors: Eckert AW, Lautner MH, Schütze A, Taubert H, Schubert J, Bilkenroth U
- Issue date: 2011 Jun
- Glucose transporter glut-1 expression correlates with tumor hypoxia and predicts metastasis-free survival in advanced carcinoma of the cervix.
- Authors: Airley R, Loncaster J, Davidson S, Bromley M, Roberts S, Patterson A, Hunter R, Stratford I, West C
- Issue date: 2001 Apr
- Overexpression of GLUT-1 in the invasion front is associated with depth of oral squamous cell carcinoma and prognosis.
- Authors: Ohba S, Fujii H, Ito S, Fujimaki M, Matsumoto F, Furukawa M, Yokoyama J, Kusunoki T, Ikeda K, Hino O
- Issue date: 2010 Jan